Skip to Main Content

Paper Details

Safety of the second dose of the ChAdOx1 nCoV-19 vaccine in people with persistent anti-platelet factor 4 antibodies.
Res Pract Thromb Haemost
3
2021
Author NameAffiliation
Watsamon JantarabenjakulDivision of Infectious Diseases Department of Pediatrics Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand.
  • 1 - 1

Datasets

Release 1.2